AP1477A - Derivatives of purine, their preparation process and pharmaceutical compositions containing them. - Google Patents

Derivatives of purine, their preparation process and pharmaceutical compositions containing them.

Info

Publication number
AP1477A
AP1477A APAP/P/2001/002355A AP2001002355A AP1477A AP 1477 A AP1477 A AP 1477A AP 2001002355 A AP2001002355 A AP 2001002355A AP 1477 A AP1477 A AP 1477A
Authority
AP
ARIPO
Prior art keywords
alkyl
aryl
purine
derivatives
represents hydrogen
Prior art date
Application number
APAP/P/2001/002355A
Other languages
English (en)
Other versions
AP2001002355A0 (en
Inventor
Jean-Luc Haesslein
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AP2001002355A0 publication Critical patent/AP2001002355A0/xx
Application granted granted Critical
Publication of AP1477A publication Critical patent/AP1477A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/2001/002355A 1999-05-21 2000-05-18 Derivatives of purine, their preparation process and pharmaceutical compositions containing them. AP1477A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9906456A FR2793794B1 (fr) 1999-05-21 1999-05-21 Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
PCT/FR2000/001335 WO2000071543A1 (fr) 1999-05-21 2000-05-18 Derives de la purine, leur procede de preparation, et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
AP2001002355A0 AP2001002355A0 (en) 2001-12-31
AP1477A true AP1477A (en) 2005-10-19

Family

ID=9545846

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2001/002355A AP1477A (en) 1999-05-21 2000-05-18 Derivatives of purine, their preparation process and pharmaceutical compositions containing them.

Country Status (33)

Country Link
US (2) US7122669B1 (OSRAM)
EP (1) EP1183256B1 (OSRAM)
JP (1) JP2003500407A (OSRAM)
KR (1) KR100707895B1 (OSRAM)
CN (1) CN1298719C (OSRAM)
AP (1) AP1477A (OSRAM)
AR (1) AR035317A1 (OSRAM)
AT (1) ATE370951T1 (OSRAM)
AU (1) AU4764500A (OSRAM)
BR (1) BR0011282A (OSRAM)
CA (1) CA2374714A1 (OSRAM)
CZ (1) CZ20014163A3 (OSRAM)
DE (1) DE60036102T2 (OSRAM)
DK (1) DK1183256T3 (OSRAM)
DZ (1) DZ3166A1 (OSRAM)
EA (1) EA005072B1 (OSRAM)
ES (1) ES2290033T3 (OSRAM)
FR (1) FR2793794B1 (OSRAM)
HU (1) HUP0201649A3 (OSRAM)
IL (1) IL146441A0 (OSRAM)
MA (1) MA26791A1 (OSRAM)
MX (1) MXPA01011834A (OSRAM)
NO (1) NO20015659L (OSRAM)
NZ (1) NZ515556A (OSRAM)
PL (1) PL352293A1 (OSRAM)
PT (1) PT1183256E (OSRAM)
SK (1) SK16722001A3 (OSRAM)
TR (1) TR200103349T2 (OSRAM)
TW (1) TWI284130B (OSRAM)
UA (1) UA68441C2 (OSRAM)
WO (1) WO2000071543A1 (OSRAM)
YU (1) YU86601A (OSRAM)
ZA (1) ZA200109602B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479487B1 (en) * 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
US6413974B1 (en) * 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
US6969720B2 (en) 1999-03-17 2005-11-29 Amr Technology, Inc. Biaryl substituted purine derivatives as potent antiproliferative agents
US6861524B2 (en) * 2000-10-31 2005-03-01 Aventis Pharmaceuticals Inc. Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
DE60138140D1 (de) * 2000-10-31 2009-05-07 Aventis Pharma Inc Acyl- und sulfonylderivative 6,9-disubstitutierter 2-(trans-1,4-diaminocyclohexyl)-purine und ihre verwendung als antiproliferative mittel
FR2818642B1 (fr) * 2000-12-26 2005-07-15 Hoechst Marion Roussel Inc Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion
US6667311B2 (en) * 2001-09-11 2003-12-23 Albany Molecular Research, Inc. Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents
US6812232B2 (en) 2001-09-11 2004-11-02 Amr Technology, Inc. Heterocycle substituted purine derivatives as potent antiproliferative agents
EP1578722A4 (en) * 2001-10-12 2006-09-06 Irm Llc KINASEINHIBITOR SCAFFOLD AND METHOD FOR THE PRODUCTION THEREOF
JP4664205B2 (ja) * 2002-10-15 2011-04-06 アイアールエム エルエルシー 骨形成を誘導する組成物および方法
FR2851248B1 (fr) * 2003-02-18 2005-04-08 Aventis Pharma Sa Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
EP1682150B1 (en) * 2003-11-10 2012-12-26 The Scripps Research Institute Compositions and methods for inducing cell dedifferentiation
AU2005231440B9 (en) * 2004-04-02 2012-02-23 Dogwood Pharmaceuticals, Inc. Selective antagonists of A2A adenosine receptors
CZ302122B6 (cs) * 2009-01-28 2010-10-20 Univerzita Palackého v Olomouci Substituované deriváty 6-(2-aminobenzylamino)purinu, jejich použití jako léciva a prípravky tyto slouceniny obsahující
WO2012142029A2 (en) 2011-04-10 2012-10-18 Florida A&M University Serms for the treatment of estrogen receptor-mediated disorders
WO2015162518A1 (en) 2014-04-25 2015-10-29 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands
WO2018064545A1 (en) * 2016-09-30 2018-04-05 Sri International Dual clk/cdk1 inhibitors for cancer treatment
CZ308029B6 (cs) 2017-03-20 2019-11-06 Univerzita PalackĂ©ho v Olomouci 2,6-Disubstituované-9-cyklopentyl-9H-puriny, jejich použití jako léčiva a farmaceutické přípravky
US20240247001A1 (en) 2022-12-16 2024-07-25 Astrazeneca Ab 2,6,9-trisubstituted purines

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0545412A2 (en) * 1991-12-05 1993-06-09 Texas Instruments Incorporated Method and apparatus to improve a video signal
WO1997016452A1 (en) * 1995-11-01 1997-05-09 Novartis Ag Purine derivatives and processes for their preparation
WO1998005335A1 (en) * 1996-08-02 1998-02-12 Cv Therapeutics, Inc. PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008858A1 (de) * 1990-03-20 1991-09-26 Hoechst Ag Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel
CA2084222C (en) * 1991-12-06 2004-04-06 David R. Borcherding Novel trans cyclopentanyl purine analogs useful as immunosuppressants
FR2741881B1 (fr) * 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques
US6790958B2 (en) * 1996-08-02 2004-09-14 Robert T. Lum Purine inhibitors of cyclin dependent kinase 2 & IKBA
AU4920397A (en) * 1996-10-11 1998-05-11 Chiron Corporation Purine inhibitors of glycogen synthase kinase 3 (gsk3)
CA2297967A1 (en) * 1997-08-07 1999-02-18 The Regents Of The University Of California Purine inhibitor of protein kinases, g proteins and polymerases
US6413974B1 (en) * 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
US6479487B1 (en) * 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
GB9903762D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
FR2818642B1 (fr) * 2000-12-26 2005-07-15 Hoechst Marion Roussel Inc Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0545412A2 (en) * 1991-12-05 1993-06-09 Texas Instruments Incorporated Method and apparatus to improve a video signal
WO1997016452A1 (en) * 1995-11-01 1997-05-09 Novartis Ag Purine derivatives and processes for their preparation
WO1998005335A1 (en) * 1996-08-02 1998-02-12 Cv Therapeutics, Inc. PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a)

Also Published As

Publication number Publication date
BR0011282A (pt) 2002-02-26
FR2793794A1 (fr) 2000-11-24
KR100707895B1 (ko) 2007-04-17
AU4764500A (en) 2000-12-12
MA26791A1 (fr) 2004-12-20
SK16722001A3 (sk) 2003-01-09
PL352293A1 (en) 2003-08-11
CA2374714A1 (fr) 2000-11-30
KR20010113975A (ko) 2001-12-28
EA005072B1 (ru) 2004-10-28
DK1183256T3 (da) 2007-12-03
EP1183256A1 (fr) 2002-03-06
DZ3166A1 (fr) 2000-11-30
TWI284130B (en) 2007-07-21
CZ20014163A3 (cs) 2002-10-16
WO2000071543A1 (fr) 2000-11-30
AP2001002355A0 (en) 2001-12-31
CN1361780A (zh) 2002-07-31
US7208598B2 (en) 2007-04-24
HUP0201649A2 (en) 2002-08-28
PT1183256E (pt) 2007-11-13
YU86601A (sh) 2005-07-19
ES2290033T3 (es) 2008-02-16
US7122669B1 (en) 2006-10-17
DE60036102T2 (de) 2008-05-15
MXPA01011834A (es) 2002-04-17
AR035317A1 (es) 2004-05-12
EA200101224A1 (ru) 2002-10-31
NZ515556A (en) 2003-08-29
US20050187228A1 (en) 2005-08-25
HUP0201649A3 (en) 2003-01-28
NO20015659D0 (no) 2001-11-20
ATE370951T1 (de) 2007-09-15
TR200103349T2 (tr) 2002-05-21
IL146441A0 (en) 2002-07-25
JP2003500407A (ja) 2003-01-07
EP1183256B1 (fr) 2007-08-22
FR2793794B1 (fr) 2001-07-27
UA68441C2 (en) 2004-08-16
DE60036102D1 (de) 2007-10-04
CN1298719C (zh) 2007-02-07
NO20015659L (no) 2002-01-18
ZA200109602B (en) 2003-01-29

Similar Documents

Publication Publication Date Title
AP1477A (en) Derivatives of purine, their preparation process and pharmaceutical compositions containing them.
DK0484573T3 (da) Physostigmin-beslægtede 4- og 6-carbamater, en fremgangsmåde og mellemprodukter til deres fremstilling og deres anvendelse som lægemidler
SE9904738D0 (sv) Novel compounds
SE9904652D0 (sv) Novel Compounds
DE50005437D1 (en) Substituierte thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)one
AR017852A1 (es) COMPUESTOS DE PIRAZOLO (3,4-b)PIRIDINA Y SUS SALES, UTILES COMO INHIBIDORES DE LAS PROTEINA-QUINASAS DEPENDIENTES DE CICLINA, Y LAS COMPOSICIONESFARMACEUTICAS QUE LOS CONTIENEN, EVENTUALMENTE ASOCIADOS CON UN AGENTE ANTICANCER.
TR199901765T2 (xx) S�lfomid-metalloproteaz inhibit�rleri
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
WO2002059102A3 (fr) Derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et utilisation
AR021662A1 (es) Derivados de la piperazina, proceso para prepararlos. las composiciones farmaceuticas que los contienen y la utilizacion de las mismas como medicamentoso para la preparacion de medicamentos
SE9902551D0 (sv) Novel compounds
NO20023001L (no) Substituerte piperazinderivater som MTP inhibitorer
ZA912618B (en) 3-aminochroman derivatives,process for preparing these and pharmaceutical compositions containing them
IL84564A (en) Fused heterocyclic tetrahydroamino- quinolinols and related compounds, a process for their preparation and pharmaceutical compositions containing them
NO995594L (no) Nye substituerte heterocykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasoeytiske sammensetninger inneholdende dem
NO301826B1 (no) Heterotricyklisk substituerte fenylcykloheksankarboksylsyrederivater, legemidler inneholdende dem og deres anvendelse for fremstilling av legemidler
ES8200691A1 (es) Procedimiento para la preparacion de nuevas cefalosporinas
AR009144A1 (es) Compuestos heterociclicos guanidilamino, composicion farmaceutica que comprende dicho compuesto y uso del mismo para la fabricacion de un medicamento
JPS57185270A (en) Novel cyclic sulfenamides, manufacture and use as drug
PL345966A1 (en) N-substituted azabicycloheptane derivatives, production and use thereof
NZ504299A (en) 1-aza-2-alkyl-6-aryl-cycloalkane compounds, a process for their preparation and pharmaceutical compositions containing them
CY1742A (en) Mitomycin analogs a process for preparing them and pharmaceutical compositions
MXPA04005839A (es) Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su preparacion y las composiciones farmaceuticas que los contienen.
ATE28457T1 (de) (5-(2-aminomethyl-imidazol-1-yl)-1,3-dialkyl-1h pyrazol-4-yl)(aryl)methanone und verfahren zu deren herstellung.
NO944888L (no) 5-(1,2,4-triazol-1-ylmetyl)-3H-isobenzofuran-1-on derivater, deres fremstilling og anvendelse som aromataseinhibitorer